Swiss Re invests in Biovotion

In addition to SwissRe, existing investor STMicroelectronics NV is participating in the round as well. The company is now in the process to add further strategically instrumental partners in a 2nd closing of this Series A round.

Biovotion, based in Switzerland, was founded in 2011 by experts in wearable monitoring and is today a leading wearable physiology monitoring company, providing integrated solutions with connected hardware and value-added monitoring services. Biovotion actively promotes the consumerisation of healthcare, providing solutions that integrate medical grade quality and reliability with ease-of-use and design of the consumer markets. Biovotion’s digital health solutions support users in keeping a healthy lifestyle, improve healthcare treatment outcomes, and aiming to reduce cost of health provisions.

Biovotion’s wearable solutions have been awarded with multiple international, prestigious prizes and high-caliber endorsements, including an XPrize award in late 2014. Biovotion’s management team is internationally recognised for its expertise in wearable monitoring. In December 2015, Biovotion has been named Europe’s most innovative medical device company by European CEO.

(SK)

Image: Biovotion